Comparative maternal-fetal outcomes associated with different antihypertensive treatment strategies in preeclampsia: a retrospective cohort study
Haiying Wu
BackgroundPreeclampsia seriously threatens maternal and infant health. Antihypertensive therapy is key to improving perinatal outcomes, yet comparative maternal-fetal evidence for oral agents remains limited.ObjectiveTo compare maternal–fetal outcomes of oral labetalol versus oral nifedipine in preeclampsia, informing individualized clinical treatment.MethodsThis retrospective cohort study included consecutive preeclampsia patients admitted from January 2023 to December 2025, divided into Labeta